These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12883448)

  • 1. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
    Chan NN; Fuller JH; Rubens M; Colhoun HM
    Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control.
    Chan NN; Vallance P; Colhoun HM
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1048-54. PubMed ID: 12714434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
    Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.
    Sørensen VR; Mathiesen ER; Clausen P; Flyvbjerg A; Feldt-Rasmussen B
    Diabet Med; 2005 Jul; 22(7):871-6. PubMed ID: 15975101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
    Woodman RJ; Playford DA; Watts GF
    Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress.
    Clapp BR; Hingorani AD; Kharbanda RK; Mohamed-Ali V; Stephens JW; Vallance P; MacAllister RJ
    Cardiovasc Res; 2004 Oct; 64(1):172-8. PubMed ID: 15364625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects.
    Colhoun HM; Slaney JM; Rubens MB; Fuller JH; Sheiham A; Curtis MA
    J Periodontal Res; 2008 Feb; 43(1):103-10. PubMed ID: 18230111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects.
    Colhoun HM; Zito F; Norman Chan N; Rubens MB; Fuller JH; Humphries SE
    Atherosclerosis; 2002 Aug; 163(2):363-9. PubMed ID: 12052484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
    Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
    Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
    Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
    Heitzer T; Rudolph V; Schwedhelm E; Karstens M; Sydow K; Ortak M; Tschentscher P; Meinertz T; Böger R; Baldus S
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1648-52. PubMed ID: 16675725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
    Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
    Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary arterial calcification is associated with albuminuria in type 2 diabetic patient.
    Yamagami K; Hosoi M; Yamamoto T; Fukumoto M; Yamakita T; Miyamoto M; Yoshioka K; Ishii T; Sato T; Tanaka S; Fujii S
    Diabetes Obes Metab; 2005 Jul; 7(4):390-6. PubMed ID: 15955125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man.
    Jilma B; Dirnberger E; Eichler HG; Matulla B; Schmetterer L; Kapiotis S; Speiser W; Wagner OF
    Thromb Haemost; 1997 Oct; 78(4):1268-71. PubMed ID: 9364996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type I diabetes mellitus.
    Skyrme-Jones RA; O'Brien RC; Meredith IT
    Clin Sci (Lond); 2000 Nov; 99(5):383-92. PubMed ID: 11052918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.